InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,382.84
(
0.21%
)
Post# of 963
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

02opida

Send PM Follow Ignore
Followers 1172
Posts 169865
Boards Moderated 4
Alias Born 12/20/2003

02opida

Member Level

Re: None

Thursday, 12/06/2012 9:47:04 AM

Thursday, December 06, 2012 9:47:04 AM

Post# of 963
The decision was significant for RBCC, as well. The company’s biotech subsidiary, Rainbow Biosciences, is close to finalizing a joint venture with Amarantus to develop and market new therapies and treatments for neurological diseases including Parkinson’s and Traumatic Brain Injury (TBI) around the world. By upholding the patent, the European Patent Office has cleared the way for potentially lucrative promotion and distribution of MANF on that continent.

History.htm

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up